Stay updated on Prevent Early Onset AD Clinical Trial
Sign up to get notified when there's something new on the Prevent Early Onset AD Clinical Trial page.
Latest updates to the Prevent Early Onset AD Clinical Trial page
- CheckyesterdayChange DetectedAdded new study sites: Dublin, Ireland (DUBLIN 4); Barcelona, Spain; and San Juan, Puerto Rico, and included Alzheimer’s Research Australia. Removed previously listed locations including Dublin (DUBLIN 4), Barcelona (Spain) and San Juan (Puerto Rico), and the Mental Health Research Institute.SummaryDifference0.5%
- Check8 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%
- Check15 days agoChange DetectedA site-wide notice about a lapse in government funding was added, including that the NIH Clinical Center is open. The page revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.3%
- Check22 days agoChange DetectedAdded a Show glossary feature and new metadata fields: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed the old fields Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%
- Check36 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%
- Check58 days agoChange DetectedThe Locations section was updated to include additional trial sites across multiple countries and regions (e.g., Alabama, California, New South Wales, Tokyo-To). This expands the list of accessible sites for the study.SummaryDifference2%
Stay in the know with updates to Prevent Early Onset AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevent Early Onset AD Clinical Trial page.